Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

Detalles Bibliográficos
Autores principales: Ito, Shun, Banno, Masahiro, Okazaki, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684857/
https://www.ncbi.nlm.nih.gov/pubmed/36414884
http://dx.doi.org/10.1007/s40121-022-00728-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684857/
https://www.ncbi.nlm.nih.gov/pubmed/36414884
http://dx.doi.org/10.1007/s40121-022-00728-3

Ejemplares similares